|
‘Incremental costs’ means by how much the studied intervention itself costs more or less than the comparator intervention
|
26
|
4.50 (1.77)
|
7
|
5.43 (1.90)
|
15
|
5.60 (1.64)
|
22
|
5.95 (1.50)
|
11
|
5.00 (1.84)
|
81
|
5.25 (1.76)
|
0.027
|
|
When an intervention in itself is cheap, it is always cost-effective compared to another intervention
|
29
|
1.76 (1.15)
|
7
|
2.29 (2.22)
|
18
|
2.89 (2.14)
|
25
|
1.32 (0.75)
|
14
|
1.64 (1.50)
|
93
|
1.88 (1.53)
|
0.027
|
|
‘Willingness to pay’ means how much a society is willing to pay for a quality-adjusted life year
|
26
|
4.19 (1.98)
|
7
|
3.86 (2.12)
|
15
|
4.87 (0.83)
|
22
|
4.64 (2.22)
|
10
|
4.40 (1.71)
|
80
|
4.44 (1.86)
|
0.73
|
|
My intervention can be cost-effective compared to another intervention, even when its societal costs are higher than the regular care
|
28
|
4.93 (1.84)
|
7
|
5.43 (2.07)
|
18
|
5.50 (1.69)
|
25
|
5.80 (1.92)
|
13
|
5.46 (1.71)
|
91
|
5.40 (1.83)
|
0.24
|
|
From a healthcare payer perspective indirect costs in full (such as 7productivity losses) are included
|
27
|
3.30 (2.15)
|
7
|
3.14 (2.04)
|
18
|
2.94 (2.16)
|
23
|
2.96 (2.18)
|
10
|
2.50 (2.12)
|
85
|
3.02 (2.11)
|
0.76
|
